Skye Bioscience, Inc. Common Stock share price logo

Skye Bioscience, Inc. Common Stock

NASDAQ: SKYE

Small Cap

$0.82

+0.01

(+0.76%)

as on

Skye Bioscience, Inc. Common Stock Stock Performance

as on May 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.77
    $0.86
    downward going graph

    6.10%

    Downside

    4.88%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.57
    $5.75
    downward going graph

    31.04%

    Downside

    601.22%

    Upside

    downward going graph

Skye Bioscience, Inc. Common Stock share price movements today

Previous Close
$0.81
Open
$0.77
Volume
720.3K
Day's Low - High
$0.77 - $0.86
52 Week Low - High
$0.57 - $5.75

Skye Bioscience, Inc. Common Stock Historical Returns

1 Month Return
-0.21 %
3 Month Return
+ 12.39 %
1 Year Return
-57.18 %
3 Year Return
-78.31 %
5 Year Return
0 %

Skye Bioscience, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Skye Bioscience, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.9M

EPS (TTM)

-0.9767

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-126.85%

Skye Bioscience, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Skye Bioscience, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Skye Bioscience, Inc. Common Stock image
Skye Bioscience, Inc. Common Stock
NA$30.9MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B115.2%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B106.5%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B40.03%17.3929.65%

Stock Returns calculator for Skye Bioscience, Inc. Common Stock Stock including INR - Dollar returns

The Skye Bioscience, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Skye Bioscience, Inc. Common Stock investment value today

Current value as on today

₹48,437

Returns

-₹51,563

(-51.56%)

Returns from Skye Bioscience, Inc. Common Stock Stock

-₹56,842 (-56.84%)

Dollar Impact

₹5,279 (+5.28%)

Indian Investors' Interest in Skye Bioscience, Inc. Common Stock Stock

Search interest for Skye Bioscience, Inc. Common Stock Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:42% versus previous 30 day period

Skye Bioscience, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
Operating Income
-4
-6
-8
-4
-10
-11
-18
-13
-14
EBITDA
-4
-4
-7
-3
-9
-10
-17
-12
40
Interest Expense
0
0
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-5
-7
-3
-9
-11
-17
-12
-14
Income Tax Expense
0
0
0
-
-
0
0
-
-
Net Income
-4
-5
-7
-3
-9
-11
-17
-12
-14
Net Profit Margin
-2705.16%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Skye Bioscience, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-3
-4
-6
-6
-7
-18
-34
-30
-58
EBITDA
-3
-4
2
-5
-7
-18
-36
-25
-57
Interest Expense
0
0
1
0
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-19
1
-6
-8
-19
-37
-26
-55
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-3
-19
1
-6
-8
-19
-37
-26
-55
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Skye Bioscience, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-5
-7
-3
-9
-11
-17
-12
11,077
-12
Operating Cash Flow
-4
-7
-5
-8
-9,185
-10
-13
-9
-8
Investing Cash Flow
1
0
-1
0
-12,808
-11
7
-2
10
Financing Cash Flow
85
-2
-
0
-
0
-
0
0
Change in Cash
82
-9
-6
-8
-21,994
-22
-5
-12
2

Skye Bioscience, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-19
1
-6
-8
-19
-37
-26
-55
Operating Cash Flow
-3
-3
-6
-6
-6
-12
-13
-25
-43
Investing Cash Flow
0
0
0
0
0
5
6
0
-19
Financing Cash Flow
3
5
6
6
13
0
16
83
0
Change in Cash
0
1
0
0
6
-7
9
58
-62

Insights on Skye Bioscience, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 43.2% return, outperforming this stock by 100.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 110.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SKYE stock has moved down by -9.4%

About Skye Bioscience, Inc. Common Stock

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
OrganisationSkye Bioscience, Inc. Common Stock
Headquarters11250 El Camino Real, San Diego, CA, United States, 92130
IndustryBiotechnology
CEOMr. Punit S. Dhillon B.A.
E-voting on sharesClick here to vote

Key Management of Skye Bioscience, Inc. Common Stock

Name

Title

Mr. Punit S. Dhillon B.A.

President, CEO & Director

Mr. Tu Diep M.Sc.

Chief Operating Officer

Mr. John P. Sharp CPA

CFO and Principal Financial & Accounting Officer

Dr. Christopher G. Twitty Ph.D.

Chief Scientific Officer

Dr. Puneet S. Arora FACE, M.D., M.S.

Chief Medical Officer

FAQs

What is Skye Bioscience, Inc. Common Stock share price today?

Skye Bioscience, Inc. Common Stock share price today is $0.82 as on at the close of the market. Skye Bioscience, Inc. Common Stock share today touched a day high of $0.86 and a low of $0.77.

What is the 52 week high and 52 week low for Skye Bioscience, Inc. Common Stock share?

Skye Bioscience, Inc. Common Stock share touched a 52 week high of $5.75 on and a 52 week low of $0.57 on . Skye Bioscience, Inc. Common Stock stock price today i.e. is closed at $0.82,which is 85.74% down from its 52 week high and 45.00% up from its 52 week low.

What is Skye Bioscience, Inc. Common Stock's market capitalisation today?

Skye Bioscience, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Skye Bioscience, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Skye Bioscience, Inc. Common Stock Shares that will get you 1.8293 shares as per Skye Bioscience, Inc. Common Stock share price of $0.82 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

Indian investors can start investing in Skye Bioscience, Inc. Common Stock (SKYE) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Skye Bioscience, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Skye Bioscience, Inc. Common Stock share’s latest price of $0.82 as on May 14, 2026 at 8:45 am IST, you will get 12.1951 shares of Skye Bioscience, Inc. Common Stock. Learn more about fractional shares .